BioSpace News Archive

Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that it filed a certificate of amendment to its certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-6 reverse stock split of its common stock.

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) ( Shanghai : 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, for the treatment of patients with glioblastoma. GLR2007 is

Coming off the successful launch of Insights, the research division of Xtelligent Healthcare Media, the publisher is offering a one-year subscription service to healthcare executives.

--New preclinical study shows vector results in significantly more hemoglobin production than vectors currently used in gene therapy for sickle cell disease and beta-thalassemia--

Medisca, a global leader in the supply of pharmaceutical-grade drugs, is proud to announce that as of February 1st, 2021, all US pharmacies will be able to access, through Medisca’s website, the manufacturer certificate of analysis (CoA) for each drug or chemical.

SK Biopharmaceuticals announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of cenobamate for the adjunctive treatment of focal-onset (partial-onset) seizures with or without secondary generalization in adult patients with epilepsy

Amarin Corporation plc (NASDAQ:AMRN) today announced that in response to Amarin’s Marketing Authorisation Application submission, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion,

Health Canada is aware that the European Medicines Agency has recommended granting a conditional marketing authorization for the COVID-19 vaccine manufactured by AstraZeneca and Oxford University.

Canada’s universal, publicly funded health system is a source of pride for Canadians. The Government of Canada is working closely with territorial governments to strengthen health care and adapt the system to the challenges of delivering health care in the North during the COVID-19 outbreak.

Tampa General Hospital, one of the most comprehensive academic medical centers in the nation, announced that it has named Qualenta Forrest, JD, its new Executive Vice President and Chief People and Talent Officer.